Pluribus Labs’s Comstock Resources CRK Stock Holding History

Pluribus Labs’s Portfolio CRK Stock Details CRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15,178	Closed	-$123K	–	93
2021 Q4	$123K	Buy	+15,178	New	+$139K	0.13%	225

Other funds holding CRK

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ACG

Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return

Pluribus Labs's CRK Position: Q1 2022 in Review

Pluribus Labs sold out of Comstock Resources (CRK) in Q1 2022, closing a stake of 15,178 shares — an estimated $123K sold.

Pluribus Labs first reported a position in CRK in Q4 2021 and held it in 1 quarter. The position peaked at $123K in Q4 2021. 186 funds tracked by Wall St. Rank hold CRK as of Q1 2022.

Pluribus Labs reported no remaining Comstock Resources position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 15,178 Comstock Resources shares in Q1 2022, an estimated $123K.
Pluribus Labs first reported a position in Comstock Resources in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Comstock Resources position peaked at $123K in Q4 2021.
186 funds tracked by Wall St. Rank held Comstock Resources as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.